Sofia Aakko, Arno Ylitalo, Heikki Kuusanmäki, Jenna H. Rannikko, Mari Björkman, Jami Mandelin, Caroline A. Heckman, Mika Kontro, Maija Hollmén. "CLEVER-1 targeting antibody, bexmarilimab, supports HLA-DR expression and alters ex vivo responsiveness to azacitidine and venetoclax in myeloid malignancies." Scientific Reports, 2025. doi:10.1038/s41598-025-01675-y